Mayne Pharma Group Limited (MYX)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today Ľ it's FREE! Already a member? Login now!

General Information
Company Name: Mayne Pharma Group Limited
Stock Code: MYX
GICS Sub-Industry: Pharmaceuticals
Market Cap ($M): 750
Equiv. Shares (M): 785

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.990 $ 0.950 $ 0.990 $ 0.950 $ 0.955 1,588,878 $ 0.035  3.665 %

Current Broker Consensus Recommendation more
Recommendation: Buy (1.6667)
Recommendation Date: 26th Mar 2015
Brokers Surveyed: 3

Company Overview

Business Description:
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. MYX also provides contract development and manufacturing services.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2016  F 40.0 5.2 119.1 18.3 1.0 1.1 100.0
2015  F 16.1 2.4 -43.5 40.1 0.0 0.0 --
2014  A 24.0 4.2 77.7 17.8 0.0 0.0 --
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F
Acrux Limited (ACR) $138 M 3.0384 -0.6083 0.1581 4.9405 12.6140 10.8924 9.64 8.77 8.45
Mayne Pharma Group (MYX) $746 M 1.0457 -0.2428 1.2152 30.3514 40.0844 18.0952 0.00 0.00 0.00

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
MYX 0.41 37.3 3.52 1.26 3.94
Market 0.88 16.6 1.30 2.38 1.59
Sector 0.81 16.7 2.72 1.27 7.80

Name Position Start Date
Mr Scott Anthony Richards Chief Executive Officer,Managing Director 13 February 2012
Mr Roger Campbell Corbett Non-Executive Chairman 17 November 2010
Mr Bruce L Mathieson Non-Executive Director 16 February 2007
Mr Ian Frank Scholes Non-Executive Director 17 October 2007
Hon Ron Best Non-Executive Director 26 July 2006
Mr William Phillips Hodges Non-Executive Director 15 November 2012
Professor Bruce G Robinson Non-Executive Director 26 August 2014

Name Position
Mark Cansdale Chief Financial Officer,Company Secretary
Stefan Cross President of Mayne Pharma USA

Substantial Shareholders
Holding Name
-- (6.30%) TIGA Trading Pty Ltd
-- (5.10%) Westpac Banking Corporation
-- (5.10%) BT Investment Management Limited
-- (7.50%) B L Mathieson

Calendar of Events
Date Event
25 February 2016 Report (Interim)
26 August 2015 Report (Prelim)
26 August 2015 Report (Annual)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Trading Using Options and Minis

This guide to using options and MINIs to improve the results of your trading is for those with some experience in trading shares.

More details...


Markets melt up

By Michael McCarthy (chief market strategist, CMC Markets) 19/12/2014 | Traders and investors caught short heading into the FOMC scrambled for cover in Europe and the US, in many cases driving indices to their best one day performance for 2015.

Aussie Investors take their foot off the accelerator

By Betty Lam (Sales Trader, CMC Markets) 18/12/2014 | Lead by the Fed-fervour offshore, Australians shares jumped on the Yellen cheer wagon. The material and energy stocks were back in vogue as both sectors gained over 3% in morning trade.

Fed Feeds Frenzy

By Michael McCarthy (chief market strategist, CMC Markets) 18/12/2014 | In spite of a frenzied pre-mortem, a benign statement from the US Federal Reserve‚Äôs Open Market Committee and steadying commodity markets drove investors back into share markets overnight. A calmer, stronger ruble helped offset European growth fears, highlighted in the overnight session by further declines in inflation.

Household brands Woolworths and Telstra Heavy Lifting

By Betty Lam (Sales Trader, CMC Markets) 11/12/2014 | Offshore jitters sent ripples through to Australian stocks. The open saw the local equities take 65 points off the index, catalysed by a mass-exit in energy stocks, yet again.

Steady open as Woodside investors wait on details of possible Wheatstone acquisition

By Ric Spooner (Chief Market Analyst, CMC Markets) 10/12/2014 | Yesterday‚Äôs news on Greek politics and China‚Äôs bond market came at a time when US and European stock markets have extended rallies and pushed valuations higher. This makes those markets vulnerable to downward corrections as profit takers act to avoid missing out.

MYEFO and Lima - December could be nasty.

BR Securities Australia Pty Ltd 2/12/2014 | December 2014 could go down as a nasty moment in Australian finance. MYEFO will reveal a deteriorating budget deficit and the UNFCCC meeting in Lima, Peru will provide the agreement, to be ratified in Paris in 2015, on how much (or little) CO2 is to be allowed into the atmosphere from 2020.


Sponsored Links